Valuation: Imricor Medical Systems, Inc.

Capitalization 403M 348M 324M 301M 561M 36.58B 603M 3.72B 1.47B 17.45B 1.51B 1.48B 63.71B P/E ratio 2025 *
-15.6x
P/E ratio 2026 * -21.5x
Enterprise value 382M 329M 306M 285M 531M 34.64B 571M 3.52B 1.39B 16.52B 1.43B 1.4B 60.33B EV / Sales 2025 *
345x
EV / Sales 2026 * 76x
Free-Float
62.1%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.90%
1 week+18.99%
Current month+22.88%
1 month+28.77%
3 months+25.33%
6 months+45.17%
Current year+22.88%
More quotes
1 week 1.7
Extreme 1.705
1.99
1 month 1.42
Extreme 1.425
1.99
Current year 1.47
Extreme 1.47
1.99
1 year 1.12
Extreme 1.115
1.99
3 years 0.18
Extreme 0.18
1.99
5 years 0.1
Extreme 0.105
2.5
10 years 0.1
Extreme 0.105
2.94
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2006
Director of Finance/CFO - 01/05/2021
Chief Tech/Sci/R&D Officer - 01/05/2020
Director TitleAgeSince
Chairman 58 01/01/2006
Director/Board Member 59 01/09/2014
Director/Board Member 60 01/05/2019
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.90%+18.99%+35.25%+478.46% 403M
-0.95%-0.02%+10.55%+5.25% 232B
-1.17%-8.74%-9.73%+104.41% 190B
-1.63%-1.00%-0.99%-14.16% 167B
-2.18%-9.80%-10.73%+91.29% 131B
-1.07%-0.45%-11.20%-7.07% 59.92B
-0.17%-0.92%+20.88%+6.96% 48.95B
-3.58%-5.98%-5.24%-10.14% 39.59B
-1.20%+2.02%+7.42%+14.29% 37.52B
-0.92%-6.34%-3.53%+29.09% 37.24B
Average -1.10%-1.22%+3.27%+69.84% 94.3B
Weighted average by Cap. -1.37%-3.79%-0.69%+33.84%
See all sector performances

Financials

2025 *2026 *
Net sales 1.1M 953K 887K 826K 1.54M 100M 1.65M 10.2M 4.02M 47.82M 4.14M 4.06M 175M 5.21M 4.49M 4.18M 3.9M 7.25M 473M 7.8M 48.13M 18.98M 226M 19.55M 19.15M 824M
Net income -24.1M -20.78M -19.34M -18.01M -33.53M -2.19B -36.07M -222M -87.73M -1.04B -90.38M -88.52M -3.81B -17.75M -15.3M -14.25M -13.26M -24.69M -1.61B -26.57M -164M -64.61M -768M -66.56M -65.19M -2.81B
Net Debt -21.42M -18.46M -17.19M -16M -29.79M -1.94B -32.05M -198M -77.95M -927M -80.31M -78.66M -3.38B -6.96M -6M -5.59M -5.2M -9.69M -632M -10.42M -64.29M -25.35M -301M -26.12M -25.58M -1.1B
More financial data * Estimated data
Logo Imricor Medical Systems, Inc.
Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices which can be used to carry out real-time interventional cardiac magnetic resonance imaging (iCMR) cardiac ablation procedures. The Company develops MRI-compatible products for cardiac catheter ablation procedures. The Vision-MR Ablation Catheter is the Company’s prime product offering, specifically designed to work under real-time MRI guidance. Its other products include Advantage-MR EP Recorder/Stimulator System, the Vision-MR Diagnostic Catheter and Vision-MR Dispersive Electrode. Advantage-MR EP Recorder/Stimulator System provides technology that allows the physician to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. It sells its capital and consumable products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.
Employees
-
More about the company
Date Price Change Volume
16/01/26 1.880 $ +1.90% 164,134
15/01/26 1.845 $ -0.27% 75,685
14/01/26 1.850 $ +1.65% 162,015
13/01/26 1.820 $ -1.62% 205,620
12/01/26 1.850 $ +17.09% 1,248,539

Delayed Quote Australian S.E., 16 January 2026 at 04:10 pm AEDT

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.256USD
Average target price
1.415USD
Spread / Average Target
+12.65%
Consensus

Quarterly revenue - Rate of surprise